Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection.
作者: FakhriRavari AlirezaMalakouti MazyarBrady Rebecca
作者单位: 1Department of Pharmacy Practice, University of the Incarnate Word Feik School of Pharmacy, San Antonio, Texas, USA.
2University of Texas Health Science Center, San Antonio, Texas, USA.
刊名: Journal of clinical and translational hepatology, 2016, Vol.4 (2), pp.97-112
来源数据库: PubMed Journal
DOI: 10.14218/JCTH.2016.00007
关键词: Direct acting antiretroviral agentsGenotype 1HCVHepatitis C
原始语种摘要: Hepatitis C virus (HCV) infection affects as many as 185 million people globally, many of whom are chronically infected and progress over time to cirrhosis, decompensated liver disease, hepatocellular carcinoma, and eventually death without a liver transplant. In the United States, HCV genotype 1 constitutes about 75% of all infections. While interferon and ribavirin therapy was the cornerstone of treatment for many years, interferon-free treatments have become the standard of care with the emergence of new direct-acting agents, resulting in more effective treatment, shorter duration of therapy, better tolerability, lower pill burden, and ultimately better adherence. This review will summarize the evidence for the currently available combination therapies as well as emerging therapies in...
全文获取路径: PubMed  (合作)

  • interferon 干扰素
  • ribavirin 三氮唑核苷
  • hepatocellular 肝细胞性的
  • currently 普遍地
  • cirrhosis 硬变
  • liver 
  • chronically 长期地
  • better 较好的
  • treatment 处理
  • infection 感染